Advertisement

Journal of Biomedical Science

, Volume 8, Issue 3, pp 229–236 | Cite as

Effects of betel chewing on the central and autonomic nervous systems

  • Nai-Shin Chu
Review

Abstract

Betel chewing has been claimed to produce a sense of well-being, euphoria, heightened alertness, sweating, salivation, a hot sensation in the body and increased capacity to work. Betel chewing also leads to habituation, addiction and withdrawal. However, the mechanisms underlying these effects remain poorly understood. Arecoline, the major alkaloid of Areca nut, has been extensively studied, and several effects of betel chewing are thought to be related to the actions of this parasympathomimetic constituent. However, betel chewing may produce complex reactions and interactions. In the presence of lime, arecoline and guvacoline in Areca nut are hydrolyzed into arecaidine and guvacine, respectively, which are strong inhibitors of GABA uptake.Piper betle flower or leaf contains aromatic phenolic compounds which have been found to stimulate the release of catecholamines in vitro. Thus, betel chewing may affect parasympathetic, GABAnergic and sympathetic functions. Betel chewing produces an increase in heart rate, blood pressure, sweating and body temperature. In addition, EEG shows widespread cortical desynchronization indicating a state of arousal. In autonomic function tests, both the sympathetic skin response and RR interval variation are affected. Betel chewing also increases plasma concentrations of norepinephrine and epinephrine. These results suggest that betel chewing mainly affects the central and autonomic nervous systems. Future studies should investigate both the acute and chronic effects of betel chewing. Such studies may further elucidate the psychoactive mechanisms responsible for the undiminished popularity of betel chewing since antiquity.

Key Words

Betel nut Betel nut chewing Central nervous system Autonomic nervous system Addiction 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Abramson LB, Brown AJ, Sitaram N. A cardioacceleratory response to low-dose arecoline infusion during sleep in patients with major depression disorder: Relationship to REM sleep induction. Psychiatry Res 19:189–198;1985.CrossRefGoogle Scholar
  2. 2.
    Burton-Bradley BG. Papua and New Guinea transcultural psychiatry: Some implications of betel chewing. Med J Aust 2:744–746;1966.PubMedGoogle Scholar
  3. 3.
    Burton-Bradley BG. Arecaidinism. Betel chewing in transcultural perspective. Can J Psychiatry 24:481–488;1979.PubMedGoogle Scholar
  4. 4.
    Calogero AE, Kamilaris TC, Gomez MT, Johnson EO, Tartaglia ME, Gold PW, Chrousos GP. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotrophin-releasing hormone-dependent mechanism. Endocrinology 125:2445–2453;1989.PubMedGoogle Scholar
  5. 5.
    Cawte J. Psychoactive substances of the South Seas: Betel, kava and pituri. Aust NZ J Psychiatry 19:83–87;1985.Google Scholar
  6. 6.
    Chen KC. The problem of betel chewing (in Chinese). Sci Mon 9:718–728;1995.Google Scholar
  7. 7.
    Christie JE, Shering A, Ferguson J, Glen AIM. Physostigmine and arecoline: Effects of intravenous infusions in Alzheimer presenile dementia. Br J Psychiatry 138:46–50;1981.PubMedGoogle Scholar
  8. 8.
    Chu EC, Chu NS. Patterns of sympathetic skin response in palmar hyperhidrosis. Clin Auton Res 7:1–4;1997.PubMedGoogle Scholar
  9. 9.
    Chu NS. Cardiovascular responses to betel chewing. J Formos Med Assoc 92:835–837;1993.PubMedGoogle Scholar
  10. 10.
    Chu NS. Effects of betel chewing on electroencephalographic activity: Spectral analysis and topographic mapping. J Formos Med Assoc 93:167–169;1994.PubMedGoogle Scholar
  11. 11.
    Chu NS. Sympathetic skin responses to betel chewing. J Formos Med Assoc 93:260–262;1994.PubMedGoogle Scholar
  12. 12.
    Chu NS. Effect of betel chewing on performance reaction time. J Formos Med Assoc 93:343–345;1994.PubMedGoogle Scholar
  13. 13.
    Chu NS. Effect of betel chewing on RR interval variation. J Formos Med Assoc 94:106–110;1995.PubMedGoogle Scholar
  14. 14.
    Chu NS. Betel chewing increases the skin temperature: Effects of atropine and propranolol. Neurosci Lett 194:130–132;1995.CrossRefPubMedGoogle Scholar
  15. 15.
    Chu NS. Sympathetic response to betel chewing. J Psychoactive Drugs 27:183–186;1995.PubMedGoogle Scholar
  16. 16.
    Chu NS, Chang CF. On the culture of betel chewing in Taiwan (in Chinese). Evergreen Mon 130:78–81;1994.Google Scholar
  17. 17.
    Deahl M. Betel nut-induced extrapyramidal syndrome: An unusual drug interaction. Mov Disord 4:330–334;1989.CrossRefPubMedGoogle Scholar
  18. 18.
    Frewer LJ. The effect of betel nut on human performance. PNG Med J 33:143–145;1990.Google Scholar
  19. 19.
    Haubrich DR, Watson DR. Effects of pilocarpine or arecoline administration on acetylcholine levels and serotonin turnover in rat brain. J Pharmacol Exp Ther 181:19–27;1972.PubMedGoogle Scholar
  20. 20.
    Huang A. Betel nuts, better not. Free China Rev 47:18–27;1997.Google Scholar
  21. 21.
    Huang LS, Wang CK, Sheu MJ, Kao LS. Phenolic compounds ofPiper betle flower as flavoring and neuronal activity modulating agents. In: Ho CT, Lee CY, Huang MT, eds. Phenolic Compounds in Food and Their Effects on Health. American Chemical Society Series 506. Washington, American Chemical Society, 200–213;1992.Google Scholar
  22. 22.
    Johnston GAR, Krogsgaard-Larsen P, Stephanson A. Betel nut constituents as inhibitors of γ-aminobutyric acid uptake. Nature 258:627–628;1975.PubMedGoogle Scholar
  23. 23.
    Ko YC, Chiang TA, Chang SJ, Hsieh SF. Prevalence of betel quid chewing habit in Taiwan and related sociodemographic factors. J Oral Pathol Med 21:261–264;1992.PubMedGoogle Scholar
  24. 24.
    Lodge D, Johnston GAR, Curtis DR, Brand SJ. Effects of the Areca nut constituents arecaidine and guvacine on the action of GABA in the cat central nervous system. Brain Res 136:513–522;1977.CrossRefPubMedGoogle Scholar
  25. 25.
    Low MD. Psychology, psychophysiology, and the EEG. In: Niedermeyer E, Lopes da Silva F, eds. Electroencephalography, ed 2. Baltimore, Urban & Schwarzenberg, 541–548;1987.Google Scholar
  26. 26.
    Mathias CJ, Christensen NJ, Corbett JL, Frankel HL, Spalding JM. Plasma catecholamines during paroxysmal neurogenic hypertension in quadriplegic man. Circ Res 39:204–208;1976.PubMedGoogle Scholar
  27. 27.
    Molinengo L, Fundaro AM, Cassone MC. Action of a chronic arecoline administration on mouse motility and on acetylcholine concentrations in the CNS. J Pharm Pharmacol 40:821–822;1988.PubMedGoogle Scholar
  28. 28.
    Nelson BS, Heischober B. Betel nut: A common drug used by naturalized citizens from India, Far East Asia, and the South Pacific islands. Ann Emerg Med 34:238–243;1999.CrossRefPubMedGoogle Scholar
  29. 29.
    Nieschulz O. Zur Pharmakologie des Wirkstoffes des Betels. Arzneimittelforschung 20:218–229;1970.PubMedGoogle Scholar
  30. 30.
    Nurnberger JI, Jimerson DC, Simmons-Alling S, Tamminga C, Nadi NS, Lawrence D, Sitaram N, Gillin JC, Gershon ES. Behavioral, physiological, and neuroendocrine responses to arecoline in normal twins and ‘well state’ bipolar patients. Psychiatry Res 9:191–200;1983.CrossRefPubMedGoogle Scholar
  31. 31.
    Nutt JG, Rosin A, Chase TN. Treatment of Huntington disease with a cholinergic agonist. Neurology 28:1061–1064;1978.PubMedGoogle Scholar
  32. 32.
    Pickwell SM, Schimelpfening S, Palinkas LA. ‘Betelmania’. Betel quid chewing by Cambodian women in the United States and its potential health effects. West J Med 160:326–330;1994.PubMedGoogle Scholar
  33. 33.
    Reichart PA. Toothpastes containing betel nut (Areca catechu L.) from England of the nineteenth century. J Hist Med Allied Sci 39:65–68;1984.PubMedGoogle Scholar
  34. 34.
    Rinaldi F, Himwich HE. Alerting responses and actions of atropine and cholinergic drugs. Arch Neurol Psychiatr 73:387–395;1955.Google Scholar
  35. 35.
    Sato A. Somatosympathetic reflexes: Afferent fibers, central pathways, discharge characteristics. Physiol Rev 53:916–947;1973.Google Scholar
  36. 36.
    Shahani BT, Day TJ, Cros D, Khalil N, Kneebone CS. RR interval variation and the sympathetic skin response in the assessment of autonomic function in peripheral neuropathy. Arch Neurol 47:659–664;1990.PubMedGoogle Scholar
  37. 37.
    Sitaram N, Weingartner H, Gillin JC. Human serial learning: Enhancement with arecoline and choline and impairment with scopolamine. Science 201:274–276;1978.Google Scholar
  38. 38.
    Stricherz ME, Pratt P. Betel quid and reaction time. Pharmacol Biochem Behav 4:627–628;1976.CrossRefPubMedGoogle Scholar
  39. 39.
    Talonu NT. Observations on betel-nut use, habituation, addiction and carcinogenosis in Papua New Guineans. PNG Med J 32:195–197;1989.Google Scholar
  40. 40.
    Taylor P. Cholinergic agonists. In: Gilman AG, Goodman LS, Gilman A, eds. The Pharmacological Basis of Therapeutics, ed 6. New York, Macmillan, 91–99;1980.Google Scholar
  41. 41.
    Von Euler US. Quantification of stress by catecholamine analysis. Clin Pharmacol Ther 5:398–404;1964.Google Scholar
  42. 42.
    Von Euler US, Domeij B. Nicotine-like actions of arecoline. Acta Pharmacol 1:263–269;1945.Google Scholar
  43. 43.
    Wang CK, Hwang LS. Phenolic compounds of betel quid chewing juice (in Chinese). Food Sci 20:458–471;1993.Google Scholar
  44. 44.
    Wang CK, Hwang LS. Analysis of the phenolic compounds in betel quid (in Chinese). J Chin Agric Chem Soc 31:623–632;1993.Google Scholar
  45. 45.
    Wang CK, Hwang LS. Effect of betel quid on catecholamine secretion from adrenal chromaffin cells. Proc Natl Sci Counc Repub China B 21:129–136;1997.PubMedGoogle Scholar
  46. 46.
    Wang CK, Lee WH, Peng CH. Contents of phenolics and alkaloids inAreca catechu Linn. during maturation. J Agric Food Chem 45:1185–1188;1997.CrossRefGoogle Scholar
  47. 47.
    Wiesner DM. Betel-nut withdrawal. Med J Aust 146:453;1987.Google Scholar
  48. 48.
    Wyatt TA. Betel nut chewing and selected psychophysiological variables. Psychol Rep 79:451–463;1996.PubMedGoogle Scholar

Copyright information

© National Science Council 2001

Authors and Affiliations

  • Nai-Shin Chu
    • 1
  1. 1.Department of NeurologyChang Gung Medical College and Memorial HospitalTaipeiTaiwan (ROC)

Personalised recommendations